Cargando…
Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis
BACKGROUND: Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunction (SND) and atrioventricular block have been previousl...
Autores principales: | Shibata, Makoto, Hoshino, Reona, Shimizu, Chisato, Sato, Masayuki, Furuta, Natsumi, Ikeda, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185934/ https://www.ncbi.nlm.nih.gov/pubmed/34102997 http://dx.doi.org/10.1186/s12883-021-02253-1 |
Ejemplares similares
-
Agranulocytosis
Publicado: (1945) -
Agranulocytosis
Publicado: (1933) -
Agranulocytosis
Publicado: (1935) -
Sinus Node Dysfunction, Atrial Arrhythmias, and the Sinus Node Microcirculation
por: Fellner, Susan K
Publicado: (2022) -
Pacemaker implantation for persistent sinus node dysfunction in a patient with COVID‐19
por: Ota, Tsuyoshi, et al.
Publicado: (2023)